US Pharma Packaging Maker To Upgrade Singapore Plant

20 August 1995

West Company Singapore (formerly West Pharmapack), a US pharmaceutical packaging manufacturer, plans to upgrade its manufacturing operations in the Republic within the next two years. The company is discussing with Singapore's Economic Development Board its reinvestment project, as well as an extension of its pioneer status, which allows a company to pay concessionary corporate tax for a specified period of time - normally five to 10 years - and which expires next year.

Under the proposed upgrading, the company's plans to install more high-technology equipment to make its Jurong plant more capital-intensive, to boost productivity and yield, said managing director Michael Teng. He added that the company expects its revenues to grow by at least 15% over the next three years, but declined to disclose this figure, or the value of the planned investment.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

More ones to watch >

Today's issue

Company Spotlight

Ironwood is a US-based biotech advancing a pipeline of medicines in multiple areas of significant unmet need, including irritable bowel syndrome with constipation ((IBS-C)/chronic idiopathic constipation (CIC), vascular and fibrotic diseases, and refractory gastroesophageal reflux disease, among others.